Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer.
<h4>Rationale</h4>Recent studies have discovered several unique tumor response subgroups outside of response classification by Response Evaluation Criteria for Solid Tumors (RECIST), such as mixed response and oligometastasis. These subtypes have a distinctive property, lesion heterogene...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/659848f0970b4b5e8a041e80db5248b8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|